Addex Therapeutics, a leading company pioneering allosteric modulation-based drug discovery and development, announced that the European Patent Office granted Addex a broad composition of matter patent (European patent, EP 1 765 795) covering dipraglurant and other mGlu5 ...
Tags: parkinsons disease, therapeutics
Show per page
1 of 1 Page
Popular tags in SelectScience